Cargando…

mTOR in Human Diseases

Detalles Bibliográficos
Autor principal:	Dormond, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540159/ https://www.ncbi.nlm.nih.gov/pubmed/31083592 http://dx.doi.org/10.3390/ijms20092351

Ejemplares similares

mTOR and Tumor Cachexia
por: Duval, Adrian P., et al.
Publicado: (2018)

Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
por: el Hage, Alexandre, et al.
Publicado: (2021)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
por: Blaser, Benjamin, et al.
Publicado: (2012)

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives
por: Dufour, Marc, et al.
Publicado: (2011)

mTOR Signaling Network in Cell Biology and Human Disease
por: Yu, Jane J., et al.
Publicado: (2022)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

Exploiting the mTOR paradox for disease prevention
por: Iglesias-Bartolome, Ramiro, et al.
Publicado: (2012)

Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy
por: Faes, Seraina, et al.
Publicado: (2017)

mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging
por: Das, Anindita, et al.
Publicado: (2017)

mTOR Signaling in Metabolism and Cancer
por: Huang, Shile
Publicado: (2020)

Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib
por: Roulin, Didier, et al.
Publicado: (2011)

mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging 2018
por: Das, Anindita, et al.
Publicado: (2019)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

Age-related mTOR in gynaecological cancers
por: Bajwa, Preety, et al.
Publicado: (2017)

Revisiting mTOR and Epithelial–Mesenchymal Transition
por: Herrerias, Mariana M., et al.
Publicado: (2020)

ROS, Klotho and mTOR in cardiorenal aging
por: Daneshgar, Nastaran, et al.
Publicado: (2020)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

mTOR pathway activation in age-related retinal disease
por: Zhao, Chen, et al.
Publicado: (2011)

mTOR pathway in familial focal epilepsies
por: Ribierre, Théo, et al.
Publicado: (2016)

mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging
por: Das, Anindita, et al.
Publicado: (2023)

microRNAs calibrate T cell responses by regulating mTOR
por: Merkenschlager, Matthias, et al.
Publicado: (2015)

VEGF-mTOR signaling links obesity and endometrial cancer
por: Sahoo, Subhransu S., et al.
Publicado: (2018)

Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
por: Scholz, Godehard, et al.
Publicado: (2016)

Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors
por: Faes, Seraina, et al.
Publicado: (2016)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

STAT3 and mTOR: co-operating to drive HIF and angiogenesis
por: Dodd, Kayleigh M., et al.
Publicado: (2015)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer
por: Floc'h, Nicolas, et al.
Publicado: (2012)

PPARγ/mTOR signalling: striking the right balance in cartilage homeostasis
por: Dell'Accio, Francesco, et al.
Publicado: (2015)

The mTOR Signalling Pathway in Human Cancer
por: Pópulo, Helena, et al.
Publicado: (2012)

Regulation of human mTOR complexes by DEPTOR
por: Wälchli, Matthias, et al.
Publicado: (2021)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

mTOR, AMBRA1, and autophagy: An intricate relationship
por: Nazio, Francesca, et al.
Publicado: (2013)

mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ks2jd4s6oauoadqui4tl3frpi1